Barely Significant
← all excerpts

Low Dose of Lenvatinib Treatment for Patients of Radioiodine-Refractory Differentiated Thyroid Carcinoma - A Real-World Experience.

Cancer Manag Res · 2021 · PMC8449554 · PMID 34548818

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

marginally significantP = 0.06so close (0.05 < p ≤ 0.1)
The initial decrement of tumor size was a marginally significant positive predictor for PFS (P = 0.06). 20 The maximal benefit was also reported in patients with a better ECOG performance status. 6 Our clinical experience obtained a similar finding.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.